Please login to the form below

Not currently logged in
Email:
Password:

John Czekanski leaves Fishawack, dna adds to team and Porterhouse announces promotions

The latest med comms movers

John Czekanski leaves Fishawack

John Czekanski

As part of its structure development, Fishawack’s global commercial head, John Czekanski has decided to leave the group.

The group said Czekanski’s decision to depart was both “mutual” and “amicable” and he will leave the business on 12 September.

During his time at Fishawack, Czekanski played a role in the integration of JK Associates, where he was chief executive before moving to Fishawack.


dna Communications appoints Jade Seidman

Jade Seidman

Medical education group dna Communicatins has added to its team in the form of Jade Seidman, who joins as its new medical writer.

Seidman was most recently an associate project manager at Synergy Medical and prior to that she was a production editor at Springer Nature.


Porterhouse Medical announces promotions and new team member

Medical communications firm Porterhouse Medical has announced two team member promotions.

Rebecca Thomas

Rebecca Thomas (pictured above) is promoted to an account manager following her work in delivering a series of events and projects.

Meanwhile, Beth Wynne-Evans has been promoted to a medical writer after her first year based in the group’s scientific services team.

Taking up a new role at Porterhouse Medical however, is Devdutt Sharma (pictured below), who joins as the group’s new associate medical writer.

Devdutt Sharma

Sharma has more than five years of scientific experience in an academic environment and has a PhD in molecular cell biology.

Article by
Gemma Jones

22nd August 2018

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Red Health

Red Health was formed in 2007 to bring something fresh to the healthcare PR world. Our approach was simple –...

Latest intelligence

Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...

Infographics